Lvmh Recherche

Institut National De La Sante Et De La Recherche Medicale

Robin Kurfurst

Carine Nizard

Sylvianne Schnebert

Eric Perrier

Jean Hubert Cauchard

Desmond J Tobin

Suman K Singh

Eric Dausse

Jean-Jacques Toulme

Jean-Christophe Archambault

Takayoshi Sakoda

Marielle Moreau

Kristell Lazou

Chantal Kurfurst

Sabrina Maniguet

Olivier Jeanneton

Bertrand Friguet

Anne-Laure Bulteau

Jean-Hubert Cauchard

Milene Juan

Jean-Baptiste Grieu

Coralie Robert

Claire Chevalier

Emmanuelle Leblanc

Sabine Rubio

Lauren Sobilo

Monique Gareil

Régine Joly

The invention relates to a cosmetic composition comprising royal jelly of the Ouessant black bee in a cosmetically acceptable medium, and to its use for regenerating and/or healing the skin.

Cosmetic composition comprising royal jelly of the Ouessant black bee

The invention relates to an aptamer that has a G-quadruplex structure and is able to inhibit the enzymatic activity of the MMP-9 protein, as well as to the dermatological and cosmetic uses thereof.

Aptamers inhibiting the enzymatic activity of the MMP-9 protein

The invention relates to a DNA aptamer that can inhibit the enzymatic activity of tyrosinase for the conversion of tyrosine into L-DOPA and dopaquinone, and to the dermatological and cosmetic uses thereof.

Aptamers inhibiting the enzymatic activity of tyrosinase

The invention relates to the use, in a cosmetic or dermatological composition, of a particular water having a pH of between 7.8 and 10 and a total dissolved solids (TDS) concentration of between 10 and 250 mg/l. The invention also relates to a cosmetic or dermatological composition containing this water. The invention relates in particular to a treatment method intended for preventing or delaying the appearance of the effects of intrinsic and/or extrinsic ageing of the skin, or for slowing down the effects thereof; for preventing or reducing pigmentary spots on the skin, or the coloration of hyperpigmented areas of skin; for reducing the pigmentation of the periphery of depigmented areas; for improving the uniformity of the skin coloration; or for lightening the complexion of the skin.

Cosmetic composition containing a particular water, and use thereof as a depigmenting or anti-ageing agent

The invention relates to methods useful in studying or modulating skin or hair pigmentation and to the use of plant extracts in compositions as well as to methods comprising the topical use of such compositions to reduce or to enhance skin or hair pigmentation.

Methods useful in studying or modulating skin or hair pigmentation, plant extracts for use in compositions and cosmetic care method

The invention relates to an aqueous solution comprising at least one tocopherol phosphate or one of its salts, at least one non-ionic surface-active agent and at least one diol. The invention also relates to a cosmetic composition advantageously obtained using the said aqueous solution. Finally, it relates to a care method using the said composition.

Composition comprising a tocopherol phosphate and preparation process

The invention relates to the use in a cosmetic composition of an extract of the alga, as a depigmenting active agent intended in particular for attenuating or eliminating skin pigmentation marks or for lightening the complexion or bodily hairs or head hair. The extract is preferably a lipid extract. The invention also relates to a cosmetic care method for attenuating or eliminating skin pigmentation marks or for lightening the complexion or bodily hairs or head hair, characterized in that it comprises the application, to at least one concerned area of the skin, of a cosmetic composition containing this extract.

[object Object]

This invention relates to oligonucleotide sequences and their derivatives. These oligonucleotide sequences are capable of hybridising with the genes or with products of the genes coding for the PKC-beta 1. This invention also relates to the use of these oligonucleotide sequences as a depigmenting or bleaching agent for the skin in a cosmetic composition or in a topical pharmaceutical composition.

Oligonucleotide and the use thereof for modulating an isoform C beta-1 protein-kinase in the form of a skin depigmentation agent

The present invention relates to novel oligonucleotide sequences and also to derivatives thereof. These novel oligonucleotide sequences are capable of hybridizing specifically with the gene or with a product of the gene encoding tyrosinase, or with the gene or a product of the gene encoding tyrosinase-related-protein 1 (TRP-1). The present invention also relates to the use of these novel oligonucleotide sequences as a depigmenting or bleaching agent in a cosmetic composition or in a dermatological composition.

Oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents

Growing community of inventors

Saint Jean de Braye, France

Robin Kurfurst